382 related articles for article (PubMed ID: 28143405)
21. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
22. Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy.
Fernagut PO; Meissner WG; Biran M; Fantin M; Bassil F; Franconi JM; Tison F
Synapse; 2014 Mar; 68(3):98-106. PubMed ID: 24243499
[TBL] [Abstract][Full Text] [Related]
23. Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease.
Torres ERS; Stanojlovic M; Zelikowsky M; Bonsberger J; Hean S; Mulligan C; Baldauf L; Fleming S; Masliah E; Chesselet MF; Fanselow MS; Richter F
Neurobiol Dis; 2021 Oct; 158():105478. PubMed ID: 34390837
[TBL] [Abstract][Full Text] [Related]
24. Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
Wakamatsu M; Iwata S; Funakoshi T; Yoshimoto M
J Neurosci Res; 2008 Feb; 86(3):640-6. PubMed ID: 17896793
[TBL] [Abstract][Full Text] [Related]
25. Treadmill exercise intervention improves gait and postural control in alpha-synuclein mouse models without inducing cerebral autophagy.
Minakaki G; Canneva F; Chevessier F; Bode F; Menges S; Timotius IK; Kalinichenko LS; Meixner H; Müller CP; Eskofier BM; Casadei N; Riess O; Schröder R; Winkler J; Xiang W; von Hörsten S; Klucken J
Behav Brain Res; 2019 May; 363():199-215. PubMed ID: 30599154
[TBL] [Abstract][Full Text] [Related]
26. Higher levels of myelin phospholipids in brains of neuronal α-Synuclein transgenic mice precede myelin loss.
Grigoletto J; Pukaß K; Gamliel A; Davidi D; Katz-Brull R; Richter-Landsberg C; Sharon R
Acta Neuropathol Commun; 2017 May; 5(1):37. PubMed ID: 28482862
[TBL] [Abstract][Full Text] [Related]
27. Reduced cerebral blood flow in an
Biju KC; Shen Q; Hernandez ET; Mader MJ; Clark RA
J Cereb Blood Flow Metab; 2020 Dec; 40(12):2441-2453. PubMed ID: 31856640
[TBL] [Abstract][Full Text] [Related]
28. Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.
Haggerty T; Credle J; Rodriguez O; Wills J; Oaks AW; Masliah E; Sidhu A
Eur J Neurosci; 2011 May; 33(9):1598-610. PubMed ID: 21453448
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies.
Price DL; Rockenstein E; Mante M; Adame A; Overk C; Spencer B; Duong-Polk KX; Bonhaus D; Lindsey J; Masliah E
Sci Rep; 2016 Jul; 6():29523. PubMed ID: 27389831
[TBL] [Abstract][Full Text] [Related]
30. Running wheel exercise reduces α-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson's disease.
Zhou W; Barkow JC; Freed CR
PLoS One; 2017; 12(12):e0190160. PubMed ID: 29272304
[TBL] [Abstract][Full Text] [Related]
31. Suppression of autophagy in the brain of transgenic mice with overexpression of А53Т-mutant α-synuclein as an early event at synucleinopathy progression.
Pupyshev AB; Korolenko TA; Akopyan AA; Amstislavskaya TG; Tikhonova MA
Neurosci Lett; 2018 Apr; 672():140-144. PubMed ID: 29203207
[TBL] [Abstract][Full Text] [Related]
32. Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy.
Singh B; Covelo A; Martell-Martínez H; Nanclares C; Sherman MA; Okematti E; Meints J; Teravskis PJ; Gallardo C; Savonenko AV; Benneyworth MA; Lesné SE; Liao D; Araque A; Lee MK
Acta Neuropathol; 2019 Oct; 138(4):551-574. PubMed ID: 31168644
[TBL] [Abstract][Full Text] [Related]
33. Mouse models of cognitive deficits due to alpha-synuclein pathology.
Magen I; Chesselet MF
J Parkinsons Dis; 2011; 1(3):217-27. PubMed ID: 23939303
[TBL] [Abstract][Full Text] [Related]
34.
Dutta AK; Armstrong C; Luo D; Das B; Spencer B; Rissman RA
ACS Chem Neurosci; 2023 Mar; 14(5):885-896. PubMed ID: 36749600
[TBL] [Abstract][Full Text] [Related]
35. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
Febbraro F; Andersen KJ; Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
Exp Neurol; 2013 Sep; 247():45-58. PubMed ID: 23531432
[TBL] [Abstract][Full Text] [Related]
36. Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression.
Fan Y; Limprasert P; Murray IV; Smith AC; Lee VM; Trojanowski JQ; Sopher BL; La Spada AR
Hum Mol Genet; 2006 Oct; 15(20):3002-11. PubMed ID: 16959793
[TBL] [Abstract][Full Text] [Related]
37. α-Synuclein in the olfactory system of a mouse model of Parkinson's disease: correlation with olfactory projections.
Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Martinez-Marcos A
Brain Struct Funct; 2012 Apr; 217(2):447-58. PubMed ID: 21928152
[TBL] [Abstract][Full Text] [Related]
38. The novel adaptive rotating beam test unmasks sensorimotor impairments in a transgenic mouse model of Parkinson's disease.
Gerstenberger J; Bauer A; Helmschrodt C; Richter A; Richter F
Behav Brain Res; 2016 May; 304():102-10. PubMed ID: 26880341
[TBL] [Abstract][Full Text] [Related]
39. Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson's disease A53T mouse model.
Flores-Cuadrado A; Saiz-Sanchez D; Mohedano-Moriano A; Martinez-Marcos A; Ubeda-Bañon I
Acta Neuropathol Commun; 2019 Apr; 7(1):56. PubMed ID: 30987677
[TBL] [Abstract][Full Text] [Related]
40. Influence of Lentiviral β-Synuclein Overexpression in the Hippocampus of a Transgenic Mouse Model of Alzheimer's Disease on Amyloid Precursor Protein Metabolism and Pathology.
Krassnig S; Schweinzer C; Taub N; Havas D; Auer E; Flunkert S; Schreibmayer W; Hutter-Paier B; Windisch M
Neurodegener Dis; 2015; 15(4):243-57. PubMed ID: 26111745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
